Synthetic Lethality Beyond BRCA: A Phase I Study of Rucaparib and Irinotecan in Metastatic Solid Tumors With Homologous Recombination-Deficiency Mutations Beyond BRCA1/2.
Saved in:
| Title: | Synthetic Lethality Beyond BRCA: A Phase I Study of Rucaparib and Irinotecan in Metastatic Solid Tumors With Homologous Recombination-Deficiency Mutations Beyond BRCA1/2. |
|---|---|
| Authors: | Tsang ES; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Dhawan MS; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Pacaud R; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Thomas S; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Grabowsky J; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Wilch L; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Karipineni S; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Kelley RK; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Ko AH; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Collisson E; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Chapman JS; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Ueda S; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Bergsland EK; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Munster P; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA. |
| Source: | JCO precision oncology [JCO Precis Oncol] 2024 Jun; Vol. 8, pp. e2300494. |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
